These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6208425)

  • 1. Central nervous system-renal interrelationship in mechanism of action of guanabenz: role of peripheral alpha 2-adrenoceptor agonist activity.
    DiBona GF
    J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S543-4. PubMed ID: 6208425
    [No Abstract]   [Full Text] [Related]  

  • 2. Different response of ANP secretion to adrenoceptor stimulation in renal hypertensive rat atria.
    Yuan K; Rhee KS; Park WH; Kim SW; Kim SH
    Peptides; 2008 Jul; 29(7):1207-15. PubMed ID: 18378355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alpha-2 agonists on renal function in hypertensive humans.
    Goldberg M; Gehr M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S34-7. PubMed ID: 2417046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet aggregation and antihypertensive alpha-adrenergic agonists].
    Imperatore A; Vairo G; Lampa E; Sasso M; Ottavo R; Scognamiglio R
    Arch Sci Med (Torino); 1980; 137(2):241-6. PubMed ID: 6111990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and peripheral actions of alpha 2-adrenergic agonists on renal function in Long-Evans and Brattleboro rats.
    Dawson R; Wallace DR
    Pharmacology; 1989; 39(4):240-52. PubMed ID: 2575260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of guanabenz therapy on renal function and body fluid composition.
    Bauer JH
    Arch Intern Med; 1983 Jun; 143(6):1163-7. PubMed ID: 6860045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.
    Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Sep; 26(3):212-29. PubMed ID: 6352237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hemodynamic and hormonal effects of central versus peripheral sympathetic inhibition in patients with congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1986; 8(5):973-7. PubMed ID: 2429099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of guanabenz: a new antihypertensive.
    Bosanac P; Dubb J; Walker B; Goldberg M; Agus ZS
    J Clin Pharmacol; 1976; 16(11-12):631-6. PubMed ID: 993358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the role of central and peripheral alpha2-adrenoceptor subtypes in gastric mucosal defense in the rat.
    Gyires K; Zádori ZS; Shujaa N; Minorics R; Falkay G; Mátyus P
    Neurochem Int; 2007 Oct; 51(5):289-96. PubMed ID: 17707950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Adrenoceptor subtypes mediating regional kidney blood flow responses to renal nerve stimulation.
    Eppel GA; Lee LL; Evans RG
    Auton Neurosci; 2004 May; 112(1-2):15-24. PubMed ID: 15233926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacologic profile of guanabenz].
    Frova C
    Minerva Cardioangiol; 1984 May; 32(5):253-6. PubMed ID: 6089037
    [No Abstract]   [Full Text] [Related]  

  • 13. Recovery of cardiac norepinephrine concentration and tyrosine hydroxylase activity by the central alpha2-adrenoceptor agonist guanabenz in rats with aortic constriction.
    Takechi S; Nomura A; Shimono H; Katoh K; Kakinoki S; Jin EZ; Akutsu M; Kitabatake A
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):409-13. PubMed ID: 10069676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of exaggerated renal sympathoinhibition during volume loading in spontaneously hypertensive rats.
    Rodriguez-Martinez M; Jones SY; DiBona GF
    J Hypertens; 1995 Dec; 13(12 Pt 1):1449-55. PubMed ID: 8866907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal alpha 2a/d-adrenoceptor subtype function: Wistar as compared to spontaneously hypertensive rats.
    Intengan HD; Smyth DD
    Br J Pharmacol; 1997 Jul; 121(5):861-6. PubMed ID: 9222541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal effects of the antihypertensive, guanabenz, in the dog.
    Strandhoy JW; Morris M; Buckalew VM
    J Pharmacol Exp Ther; 1982 May; 221(2):347-52. PubMed ID: 7077529
    [No Abstract]   [Full Text] [Related]  

  • 17. Natriuretic and water diuretic effects of central alpha 2-adrenoceptor agonists.
    Gehr M; MacCarthy EP; Goldberg M
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S781-6. PubMed ID: 6084125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanabenz effects on blood pressure and noninvasive parameters of cardiac performance in patients with hypertension.
    Shah RS; Walker BR; Vanov SK; Helfant RH
    Clin Pharmacol Ther; 1976 Jun; 19(6):732-7. PubMed ID: 773584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanabenz, an alpha2-selective adrenergic agonist, activates Ca2+-dependent chloride currents in cystic fibrosis human airway epithelial cells.
    Norez C; Vandebrouck C; Antigny F; Dannhoffer L; Blondel M; Becq F
    Eur J Pharmacol; 2008 Sep; 592(1-3):33-40. PubMed ID: 18640110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between guanabenz and clonidine in their antinociceptive effects in the rat.
    Chan JY; Chan SH
    Exp Neurol; 1987 Apr; 96(1):233-6. PubMed ID: 3556516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.